Mucopolysaccharidosis Type IIIA, Sanfilippo Syndrome Type A, MPS IIIA
A lysosome is a structure within the cell that digests and removes waste. When the lysosome cannot recycle waste properly, the waste accumulates and causes the cell to die. Mucopolysaccharidoses (MPS) are defined by abnormal buildup of glycosaminoglycans, large sugar-protein molecules that are important for skeletal and joint function.
-
Signs and symptoms
Affected dogs are ataxic, have abnormal eye movements, and head tremors.
Signs typically develop around 18 months of age, and most dogs do not survive more than a few months after diagnosis. -
Diagnosis
Genetic and laboratory testing used to diagnose this disease.
-
Treatment
There is no treatment except supportive care for the clinical signs the affected dog develops.
-
What to do if your dog is at risk
Actions
- Focus on palliative therapies to increase your dog's comfort and quality of life.
-
Genetic Information
This mutation was first described in the New Zealand Huntaway.
This mutation is inherited in an autosomal recessive manner; that is, a dog requires two copies of the mutation to show signs of the disease.
Gene names:
SGSH ‐ chr
Inheritance type:
recessive
Citations:
-
Breeds affected
This health condition affects the following breeds
Learn about your dog’s unique genetic health
Dog owners
Breed identification, health and trait insights, personalized care recommendations, and the world’s first canine relative finder—all in one leading dog DNA test.
Learn about the report for dog ownersShop the test
Breeding programs
Embark’s test for breeding programs is one comprehensive DNA test designed with your needs in mind.
Learn about the report for breedersShop the test
